References
- Fry C L, Treloar C, Maher L. Ethical challenges and responses in harm reduction research: Promoting applied communitarian ethics. Drug Alcohol Rev 2005; 24: 449–459
- Hathaway A. Ushering in another harm reduction era? Discursive authenticity, drug policy and research. Drug Alcohol Rev 2005; 24: 549–550
- Keane H. Moral frameworks, ethical engagement and harm reduction: commentary on ‘Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics’ by C. L. Fry, C. Treloar & L. Maher. Drug Alcohol Rev 2005; 24: 551–552
- Miller P. Harm reduction ethics: a promising basis for drug policy. Drug Alcohol Rev 2005; 24: 553–554
- Loff B. Ethical challenges and responses in harm reduction research: a critique of applied communitarian ethics. Drug Alcohol Rev 2006; 25: 371–372
- Mooney G. We still need communitarian ethics in harm reduction research. Drug Alcohol Rev 2006; 25: 373–374
- Bell D. Communitarianism. The Stanford encyclopedia of philosophy, E N Zalta. Stanford University, Stanford, CA 2004, Available at: http://plato.stanford.edu/entries/communitarianism/ (accessed 5 March 2007)
- Sayers S. Individual and society in Marx and Hegel: beyond the communitarian critique of liberalism. Sci Soc 2007; 71: 84–102
- Callahan D, Jennings B. Ethics and public health: forging a strong relationship. Am J Public Health 2002; 92: 169–176
- Roberts M J, Reich M R. Ethical analysis in public health. Lancet 2002; 359: 1055–1059
- Fry C, Madden A, Brogan D, Loff B. Australian resources for ethical participatory processes in public health research. J Med Ethics 2006; 32: 186
- Higgs P, Moore D, Aitken C. Engagement, reciprocity and advocacy: ethical harm reduction practice in research with injecting drug users. Drug Alcohol Rev 2006; 25: 419–423
- Irwin K, Fry C L. Strengthening drug policy and practice through ethics engagement: An old challenge for a new harm reduction. Int J Drug Policy 2007; 18: 75–83, Available at: doi: 10.1016/j.drugpo.2006.12.002 (accessed 5 March 2007)